China SXT Pharmaceuticals, Inc. (SXTC)
Stock Price: $0.380 USD
0.073 (23.82%)
Updated December 3, 4:00 PM EST - Market closed
After-hours: $0.370 -0.010 (-2.50%) Dec 3, 7:59 PM
Stock Price Chart
Key Info
| Market Cap | 13.16M |
| Revenue (ttm) | 330,430 |
| Net Income (ttm) | -10.29M |
| Shares Out | 24.73M |
| EPS (ttm) | -0.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | December 3 |
| Last Price | $0.380 |
| Previous Close | $0.307 |
| Change ($) | 0.073 |
| Change (%) | 23.82% |
| Day's Open | 0.403 |
| Day's Range | 0.341 - 0.455 |
| Day's Volume | 40,768,809 |
| 52-Week Range | 0.232 - 1.440 |
More Stats
| Market Cap | 13.16M |
| Enterprise Value | 11.01M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 24.73M |
| Float | n/a |
| EPS (basic) | -0.42 |
| EPS (diluted) | -0.42 |
| FCF / Share | 0.02 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 4.01% |
| Payout Ratio | n/a |
| Shares Short | 106,554 |
| Short Ratio | 0.05 |
| Short % of Float | n/a |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | 24.94 |
| PS Ratio | 39.82 |
| PB Ratio | 1.89 |
| Revenue | 330,430 |
| Operating Income | -1.26M |
| Net Income | -10.29M |
| Free Cash Flow | 527,589 |
| Net Cash | 2.15M |
| Net Cash / Share | 0.06 |
| Gross Margin | 52.37% |
| Operating Margin | -380.06% |
| Profit Margin | -3,113.50% |
| FCF Margin | 159.67% |
| ROA | -4.28% |
| ROE | -100.33% |
| ROIC | -128.90% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Consensus: n/a
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 0.33 | 0.21 | 1.32 | 0.73 |
| Revenue Growth | 55.75% | -83.89% | 80.04% | - |
| Gross Profit | 2.79 | 2.61 | 4.93 | 3.30 |
| Operating Income | -1.26 | -0.23 | 3.17 | 2.59 |
| Net Income | -10.29 | 1.54 | 1.19 | 1.19 |
| Shares Outstanding | 24.73 | 20.57 | 20.00 | 20.00 |
| Earnings Per Share | -0.42 | 0.08 | 0.06 | 0.06 |
| EPS Growth | - | 27.12% | 0% | - |
| Operating Cash Flow | 0.93 | 0.24 | 1.92 | 0.29 |
| Capital Expenditures | -0.41 | -0.60 | -1.03 | -0.18 |
| Free Cash Flow | 0.53 | -0.36 | 0.89 | 0.11 |
| Cash & Equivalents | 8.87 | 9.37 | 0.96 | 0.07 |
| Total Debt | 6.72 | 0.30 | 0.39 | 0.30 |
| Net Cash / Debt | 2.15 | 9.07 | 0.58 | -0.24 |
| Assets | 21.70 | 17.47 | 7.66 | 5.43 |
| Liabilities | 12.30 | 6.36 | 4.37 | 3.58 |
| Book Value | 9.40 | 11.11 | 3.29 | 1.85 |
Numbers in millions USD, except per-share numbers.
Company Profile
Company Details
| Full Name | China SXT Pharmaceuticals, Inc. |
| Employees | 97 |
Stock Information
| Ticker Symbol | SXTC |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Unique Identifier | NASDAQ: SXTC |
| IPO Date | January 4, 2019 |
Description
China SXT Pharmaceuticals, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of May 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. The company was founded in 2005 and is based in Taizhou, China.